Measuring the Cost Effectiveness of HIV Prevention Interventions in the US: Pitfalls and Problems

Hellinger, Fred J.

doi:10.1007/s40258-015-0158-5

Cited by 2 publications

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In summary, we found in a retrospective cohort study that the presence of malignancy as a comorbidity was a significant predictor of 30-day hospital readmission in HIV-1-infected patients. If our findings are reproduced at other centers in a prospective manner this would assist in evidence based cost effective utilization of resources and attention to this high-risk population for 30-day-hospital readmission [17].…”

Section: Discussionmentioning

confidence: 80%

The Presence of a Malignant Comorbidity is a Significant Predictor of Increased 30-Day Hospital Readmission Rates in HIV-1 Infected Individuals

Rico¹

2015

J AIDS Clin Res

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 80%

The Presence of a Malignant Comorbidity is a Significant Predictor of Increased 30-Day Hospital Readmission Rates in HIV-1 Infected Individuals

Rico¹

2015

J AIDS Clin Res

View full text Add to dashboard Cite

show abstract

“…With the introduction of highly active antiretroviral therapy (HAART) HIV-1-infected patients are living longer [1]. Unfortunately HIV-1-infected individuals suffer significantly compared to their HIV-1-uninfected peers in terms of cancer diagnosis and mortality, hospital readmissions, and impact on health care utilization [2][3][4][5][6]. Comorbidities as well as chronic co-infections are becoming an increasing concern to patients and treating clinicians [1,6,7].…”

Section: Introductionmentioning

confidence: 99%

Co-infection with Hepatitis C Virus Increases Mortality in HIV-1 infected Patients through Increased Liver-Related Deaths Rather Than By Increasing Malignancy Related Deaths

Griffin¹,

Metzger²

2016

J AIDS Clin Res

View full text Add to dashboard Cite

Background: HIV-1-infected patients are living longer since the introduction of highly effective antiretroviral therapy (HAART). There is evidence that hepatitis C virus (HCV)/HIV-1 co-infection may result in an increased risk of death compared to patients infected only with HIV-1. Prior studies looking at this association have been limited by their enrollment of populations composed of mainly young MSM males. We investigated HCV/HIV-1-co-infection for an increased odds ratio for all cause mortality in a cohort representative of the current population in the US living with HIV-1-infection. Methods: We performed an age-and-sex 1:1 matched case control study. We evaluated all deaths (n=153) that occurred in a cohort of ~2000 patients from January 1, 2010-December 31, 2014 (~10,000 patient life years) at a suburban clinic outside the NYC metropolitan area with a significant number of women and older individuals living with HIV-1-infection. We compared this cohort to an age and sex matched population selected from among 395 enrolled living HIV-1-infected controls. Results: We observed that HCV/HIV-1-co-infection was associated with an increased odds ratio for all cause mortality of 1.83 (95% CI, 0.99, 3.43; P=0.038) compared to HIV-1-mono-infected patients. Liver related deaths were the main cause of death with an odds ratio for liver related death with of 6.59 (95% CI, 1.70, 25.70; P=0.0005). Conclusion: In an HIV-1-infected cohort, HCV/HIV-1-co-infection is associated with an increased odds ratio for all cause mortality driven by liver related mortality. J o ur nal o f A ID S & Cli n ic a l R es earc h

show abstract

Measuring the Cost Effectiveness of HIV Prevention Interventions in the US: Pitfalls and Problems

Cited by 2 publications

References 16 publications

The Presence of a Malignant Comorbidity is a Significant Predictor of Increased 30-Day Hospital Readmission Rates in HIV-1 Infected Individuals

The Presence of a Malignant Comorbidity is a Significant Predictor of Increased 30-Day Hospital Readmission Rates in HIV-1 Infected Individuals

Co-infection with Hepatitis C Virus Increases Mortality in HIV-1 infected Patients through Increased Liver-Related Deaths Rather Than By Increasing Malignancy Related Deaths

Contact Info

Product

Resources

About